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Abstract 
 
The importance of calcium as well as its 
interdependence upon vitamin D is well 
established. Vitamin D acts via the vitamin D 
receptor, which is found in 37 different 
human tissues. Because of its rather 
ubiquitous localization, vitamin D is the topic 
of a great deal of associative research. 
However, caution must be exercised in 
interpreting these initial studies until clear 
evidence for causality becomes available. 
The purpose of this article is to review some 
of the known vitamin D and calcium 
associations as well as the current 
guidelines for calcium and vitamin D 
supplementation in the reproductive female. 
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Introduction 
 
Calcium is essential for muscle 
contraction, second messenger 
formation, secretion of 
neurotransmitters and hormones, 
blood coagulation, and bone 
metabolism. Its availability for these 
essential functions is dependent 
upon dietary intake of calcium and 
vitamin D as well as gut absorption 
and bone metabolism. In particular, 
uptake of calcium requires prior 
vitamin D uptake and metabolism.  
 
Vitamin D is not merely a vitamin but 
a highly regulated steroid hormone 
system with several derivatives and 
metabolites. Vitamin D2 is a plant-
derived molecule that is ingested, 
whereas vitamin D3 is a derivative of 
cholesterol that can also be ingested 
or formed in the skin via ultraviolet 
light. Vitamin D is then converted in 
the liver to 25-hydroxyvitamin D 
(25(OH)D),  which is the precursor of 
the active metabolite. Final 
conversion to the active metabolite, 
1,25-dihydroxyvitamin D occurs in 
the kidney. Vitamin D then acts via 
the vitamin D receptor  (VDR). 
Because the VDR is found in 37 
different human tissues, vitamin D is 
linked to a multitude of biological and 
pathological processes. However, 
caution must be exercised in 
interpreting these studies until clear 
evidence for causality becomes 
available. The purpose of this article 
is to review some of the known 
vitamin D and calcium associations 
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with clinical condition as well as the 
current guidelines for calcium and 
vitamin D supplementation in women 
of reproductive age.  
 
Defining calcium and vitamin D 
deficiency  
 
The levels of total calcium remain 
relatively stable throughout a 
women’s reproductive life. During 
pregnancy, 25-30 grams of calcium 
are transferred to the fetus via active 
transport. Most of this transfer 
occurs in the 2nd and 3rd trimester 
when mineralization of the fetal 
skeleton occurs. Increased 
absorption in the gut allows this 
transfer while relatively preserving 
the maternal skeleton. This 
increased absorption is balanced not 
only by the fetal transfer but also by 
increased urinary excretion.  
 
Vitamin D and its metabolites play an 
important role in calcium 
homeostasis and bone metabolism. 
Vitamin D is the only vitamin that can 
be derived in humans as well as 
ingested. In healthy adults, vitamin D 
levels are maintained by appropriate 
dietary intake as well as sun 
exposure.  
 
Severe vitamin D deficiency is 
characterized by muscle weakness, 
bone pain, and fragility fractures. In 
assessing vitamin D deficiency, it is 
important to measure 25(OH)D.  
While it is not the most active 
metabolite it does represent body 
stores. In the past, the level at which 
a patient was considered deficient 
was <10 ng/ml. Today, controversy 
exists as to what constitutes 
insufficiency. Most literature quotes 
levels < 30 ng/ml; however the 
Institute of Medicine defines 
insufficiency as < 
 
20 ng/ml. It should 
be noted that 97% of the population 
has levels of 20 ng/ml, which is 
generally considered to be adequate. 
Women are often insufficient in both 
calcium and vitamin D 
 
From a young age, women often do 
not have appropriate calcium intake, 
such that 13% of girls age 12-19 and 
22% of women above the age of 20 
are deficient in calcium. In a report 
from the 3rd National Health and 
Nutrition and Examination Survey, 
which used 30 ng/ml to define 
sufficiency, 69% of pregnant women 
and 78% of non-pregnant women 
age 13-44 were reported to have 
vitamin D insufficiency.1  
 
Maternal insufficiency of calcium and 
vitamin D correlates with fetal 
insufficiency. In the 2010 study by 
Karim et al, a positive correlation 
between the level of vitamin D in 
maternal serum and cord blood was 
found, with a high prevalence of both 
insufficiency (20-29ng/ml)  and 
deficiency (<20ng/ml) in the maternal 
sample population. Fetal Vitamin D 
levels were categorized as sufficient 
(>33ng/ml) or deficient (<33ng/dl). 
This study was conducted on 50 
consecutive women presenting in 
labor with a singleton term 
pregnancy at a tertiary care center in 
Pakistan. Maternal blood take prior 
to delivery was compared to cord 
blood at the time of delivery. 
Maternal deficiency was noted in 23 
(46%) and insufficiency in 16 (32%) 
while fetal insufficiency was noted in 
44 infants (88%). Maternal Vitamin D 
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levels were significantly correlated to 
sunlight exposure and 
diet.(P<.0007).2   
 
A little history of vitamin D 
 
The clinical presentation of rickets, 
which is caused by vitamin D 
deficiency, was first described in 
children in the mid-17th century. 
Vitamin D deficiency was noted to 
cause lifelong bone deformities in 
weight bearing bones including the 
pelvis. In the early 19th century in 
Glasgow, it was reported that one 
out of thirty deliveries required 
destruction of the fetal cranium 
because of a rachitic maternal 
pelvis.3 In the British Medical Journal 
in 1890, Murdoch Cameron 
introduced c-sections into practice 
for women with a deformed pelvis.4 
An early 20th century public health 
campaign greatly reduced the 
prevalence of vitamin D deficiency. 
Unfortunately, rickets has started to 
re-emerge in the pediatric literature, 
potentially because of the current 
practice of avoiding ultraviolet light to 
decrease the incidence of skin 
cancer. 
 
The significance of calcium and 
vitamin D: classic ideas 
 
Calcium is important for skeletal 
mineralization in the reproductive 
female. Sufficient maternal calcium 
intake is critical to maintain adequate 
circulating values and thereby avoid 
maternal skeletal depletion in 
pregnancy and lactation. Maternal 
calcium intake also affects circulating 
calcium levels in infants. 
Approximately 210 mg/day of 
calcium is secreted into the breast 
milk. The source of this maternal 
calcium is increased bone 
mineralization and decreased urinary 
excretion. Not surprisingly, a 2-5% 
loss in bone density occurs during 
pregnancy and lactation, but it 
rebounds with the resumption of 
menses. In addition to calcium, fat 
soluble vitamins (D, A, E) are also 
secreted into breast milk. Vitamin D 
levels in newborns (the first postnatal 
6-8 weeks) are largely dependent 
upon pre-natal stores. Like with 
calcium, vitamin D levels in breast 
fed infants reflect maternal intake.  
Human breast milk has 20-60 
IU/liter, which is 1.5-3% of the 
maternal levels of vitamin D. 
Therefore, it is recommended that all 
breast fed infants are supplemented 
with 400 IU of vitamin D daily. 
Another possible strategy to increase 
infant vitamin D intake is to increase 
maternal intake. In a small study of 
18 women, 4000 IU maternal 
supplementation substantially 
increased the vitamin D content of 
breast milk.5 To attain the 
recommended daily allowance in 
formula fed infants, 400 IU/liter is 
added to all formula in the US. 
 
Non Classical Associations 
 
Preconception 
 
Vitamin D is thought to be important 
in the preconception period. For 
example, animal studies 
demonstrate impaired fertility, likely 
attributed to abnormal ovulatory 
function, in vitamin D-deficient rats.6 
Mice devoid of α1-hydroxylase have 
hypoplastic reproductive organ 
development.7 Finally, VDR null mice 
are infertile but develop normal 
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fertility with a calcium-rich diet.8 A 
prospective cohort study revealed 
that higher 25(OH)D levels in serum 
and follicular fluid predicted success 
of in vitro fertilization (IVF), even 
after adjustment for age, body mass 
index (BMI), ethnicity, and number of 
embryos.9 Interestingly, there was no 
increase in ovulation, and the 
authors postulated that the increased 
levels of 25(OH)D improved 
receptivity and implantation.  
 
Polycystic Ovarian Syndrome 
 
While no randomized control trials 
have examined the effect of vitamin 
D and/or calcium supplementation in 
women with polycystic ovarian 
syndrome (PCOS), several small 
trials have demonstrated some 
improvements in PCOS patients with 
vitamin D and calcium treatment. 
Thys-Jacobs et al demonstrated that 
calcium and vitamin D (1500mg 
supplement) treatment normalized 
menstrual cycles in 54% (7/13) of 
women with PCOS.10 In another 
study of 15 PCOS patients, insulin 
secretion was improved with vitamin 
D treatment.11 A pilot study in which 
women were treated with metformin, 
calcium, and vitamin D, improved 
number dominant follicles >14mm 
were observed.12 
  
Pre-eclampsia 
 
The role of calcium in pre-eclampsia 
was first examined in the Calcium for 
Pre-Eclampsia Prevention Trial 
(CPEP) in 1997.13 In this study, 4589 
women at 13-21 weeks of gestation 
were randomized in a placebo-
controlled double blinded trial to daily 
supplementation with 2000 mg 
calcium versus placebo for the 
remainder of pregnancy. 
Unfortunately, no difference was 
found in the development of 
gestational hypertension, pre-
eclampsia, or adverse perinatal 
outcomes in healthy nulliparous 
women with or without calcium 
supplementation.  In 2006, the World 
Health Organization reported results 
from a randomized placebo-
controlled double blind trial of 8325 
pregnant women with low calcium 
intake (< 600 mg/day) with calcium 
supplementation.14 The subjects 
were enrolled prior to 20 gestational 
weeks and randomized to receive 
1500 mg of calcium per day versus 
placebo for the duration of 
pregnancy. Supplementation did not 
prevent pre-eclampsia but it did 
reduce its severity, along with 
reducing maternal and neonatal 
morbidity. In a Cochrane database 
review of >15,000 women in 12 
trials, supplementation with at least 1 
gram of calcium daily during 
pregnancy compared to placebo 
reduced the risk of both gestational 
hypertension (RR 0.65) and pre-
eclampsia (RR 0.45).15 The women 
in a majority of the studies included 
in this meta-analysis could be 
categorized as having a low risk 
pregnancy as well as a low calcium 
diet.  
 
Pre-eclampsia has been associated 
with low 1,25 dihydroxyvitamin D 
levels secondary to reduced 
expression and activity of α1-
hydroxylase in the placenta. 
Interestingly, a study by Bodnar et al 
of 274 women found a significant 
association between low 25(OH)D 
concentrations in early pregnancy 
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and the development of pre-
eclampsia.16 25 (OH)D levels were 
measured at 16 weeks and then the 
patients were followed for the 
duration of pregnancy and outcomes 
measured. The 55 women who 
developed pre-eclampsia had 
significantly lower levels of 25(OH)D 
than those that did not; however 
these women were not vitamin D 
deficient. Those who developed pre-
eclampsia had a mean Vitamin D 
level of 45.4nmol/l (38.6-53/4 
nmol/L) vs. 53.1nmol/L (47.1-
59.9nmol/L). The authors concluded 
that vitamin D deficiency may be an 
independent risk factor for pre-
eclampsia. Finally an epidemiologic 
study of 23,423 Norwegian women 
identified a 27% risk reduction for 
developing pre-eclampsia with 
vitamin D supplementation 
compared to no supplementation.17  
 
Gestational Diabetes 
 
1,25 dihydroxyvitamin D is known to 
stimulate insulin production and 
improve insulin sensitivity; therefore 
investigators have tried to link 
vitamin D deficiency with gestational 
diabetes. No randomized control 
trials are available, but two cross 
sectional studies demonstrated lower 
25 (OH) levels in gestational 
diabetes mellitus (GDM) when 
compared to controls.18,19 A third 
cross sectional study of Indian 
mothers found no association.20 One 
prospective case controlled study 
demonstrated that vitamin D 
deficiency (24.2 vs 30.1 ng/ml) at 16 
weeks of gestation was associated 
with increased risk for GDM 
development. 33% of gestational 
diabetic cases had Vitamin D levels 
<20ng/ml compared with 14% of 
controls.21 
  
Mode of delivery, preterm birth, and 
low birth weight 
 
To understand how vitamin D 
deficiency contributes to the mode of 
delivery, one study measured the 
maternal and neonatal 25(OH)D 
levels and found that women with 
deficiency in vitamin D were four 
times more likely to have a primary 
c-section.22 The authors’ explanation 
for this finding is related to the fact 
that skeletal muscle contains the 
vitamin D receptor such that vitamin 
D deficiency is associated with 
suboptimal muscle performance and 
strength.   
 
With regards to birth weight, in the 
1980’s, the initial randomized 
controlled trial showed that vitamin D 
supplementation leads to fewer small 
for gestational age infants.23 
However, conflicting data from 
France reported no difference in birth 
weight between groups receiving 
20,000 IU or 2000 IU vitamin D as 
compared to placebo.24 However, 
maternal milk intake has been 
correlated with larger infants in two 
separate trials, one in Canada25 and 
a larger cohort study in the 
Netherlands.26 No randomized 
control trials of vitamin D 
replacement and preterm birth have 
been published until an abstract 
reported at the 2010 Pediatric 
Academic Societies Meeting.27 In 
this study, 350 women were 
randomized to three different vitamin 
D supplemental regimens 400 IU, 
2000 IU, and 4000IU. The authors 
conclude that vitamin D sufficiency 
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correlated with decreased risk for 
preterm birth, infection, and co-
morbidities of pregnancy with the 
greatest effect at 4000 IU/day. No 
adverse effects were noted with any 
treatment group.  
 
A word of caution 
 
In 2011, the Institute of Medicine 
(IOM) reviewed its recommendations 
for calcium and vitamin D and made 
very few changes from previous 
years. Under these guidelines, 
women aged 14-50, regardless of 
pregnancy or lactation, need 1000 
mg of calcium and 600 IU of vitamin 
D/day (Table 1). Women above 51 
years of age require 1200 mg of 
calcium and 600 IU of vitamin D until 
the age of 71, when they should 
increase vitamin D intake to 800 IU. 
According to this report, “The data 
just aren’t there to recommend 
people consume higher amounts of 
vitamin D or calcium.” The upper 
limit of recommended intake is 2500 
mg calcium and 4,000 IU vitamin D 
per day. The upper limit includes 
dietary intake, and most people get 
600-900 mg of calcium from dietary 
sources. Of note, 5% of 
postmenopausal women are taking 
more than the daily recommended 
allowance, which increases the risk 
for kidney stones and possibly 
cardiovascular disease.30 
Controversy regarding optimal 
vitamin D supplementation exists. 
Many suggest that most individuals 
can benefit from a supplement, 
especially in the winter months.28 
  
 
Table 1: Revised daily dietary allowance recommendations for calcium 
and vitamin D in reproductive female* 
 
  Calcium  Vitamin D 
Age (yrs) Estimated 
Average 
Requirement 
(mg/day) 
Recommended 
Dietary 
Allowance 
(mg/day) 
Upper 
Level 
Intake 
(mg/day) 
Estimated 
Average 
Requirement 
(mg/day) 
Recommended 
Dietary 
Allowance 
(mg/day) 
Upper 
Level 
Intake 
(mg/day) 
14-19 1100 1300 3000 400 600 4000 
19-50 800 1000 2500 400 600 4000 
51-70 1000 1200 2000 400 600 4000 
>70† 1000 1200 2000 400 800 4000 
14-18 
pregnant/ 
lactating 
1100 1300 3000 400 600 4000 
19-50 
pregnant/ 
lactating 
800 1000 2500 400 600 4000 
 
*Adapted from the Institute of Medicine 2011 consensus report of dietary reference intakes for calcium and vitamin D 
†denotes the only revised recommended dietary allowance 
 
 
 
 
Screening 
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No formal screening guidelines exist. 
The IOM states we should not 
routinely screen, but take inventory 
and screen those at risk for 
deficiency based on diet and sun 
exposure, specifically habitation in 
the northern latitudes, regular 
sunscreen use, dark skin, obesity, 
aging, or malabsorptive syndromes. 
Interpretation of the results may be 
challenging, especially if the lab is 
not a reference lab. In May of 2010, 
Mulligan et al published a clinical 
opinion in the American Journal of 
Obstetrics and Gynecology. They 
stated that women with one or more 
risk factors should have vitamin D 
levels evaluated at the first prenatal 
visit and again mid-way through 
pregnancy.29 According to these 
authors, caregivers should target a 
range between 32-100 ng/dl and 
treat with 2000-4000 IU to achieve it. 
It should be noted that the average 
vitamin D supplementation in 
prenatal vitamins is 400 IU.  
 
Conclusions 
 
Calcium and vitamin D are important 
to the reproductive female. 
Deficiency leads to serious skeletal 
consequences (rickets), yet optimum 
levels or sufficiency is widely 
debated. Most literature and 
reference labs set 30 ng/ml as 
sufficient although the Institute of 
Medicine uses 20 ng/ml as the 
standard. Caution should be used in 
reviewing literature linking vitamin D 
to various disease states as very few 
randomized trial exists, and the 
findings have not been replicated. 
No formal screening guidelines exist 
for vitamin D deficiency, but given 
the variable sun exposure and level 
of obesity in Iowa, many of our 
patients have risk factors. Vitamin D 
levels should be measured by 25 
(OH)D and only sent to reference 
laboratories to ensure a correct 
reading. Supplementation with up to 
4000 IU/day is safe but not 
recommended by the Institute of 
Medicine. In short, further research 
is needed.  
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